Al-Tamimi M, Khan AQ, Anver R (2022) Pristimerin mediated anticancer effects and sensitization of human skin cancer cells through modulation of MAPK signaling pathways. Biomed Pharmacother 156:113950. https://doi.org/10.1016/j.biopha.2022.113950

Article  CAS  PubMed  Google Scholar 

Ankli A, Heilmann J, Heinrich M, Sticher O (2000) Cytotoxic cardenolides and antibacterial terpenoids from Crossopetalum gaumeri. Phytochemistry 54:531–537. https://doi.org/10.1016/S0031-9422(00)00144-8

Article  CAS  PubMed  Google Scholar 

Araujo-Leon JA, Cantillo-Ciau Z, Ruiz-Ciau DV, Coral-Martinez TI (2019) HPLC profile and simultaneous quantitative analysis of tingenone and pristimerin in four Celastraceae species using HPLC-DAD-MS. Rev Bras Farmacogn 29:171–176. https://doi.org/10.1016/j.bjp.2018.12.009

Article  CAS  Google Scholar 

Avilla J, Teixido A, Velazquez C, Alvarenga N, Ferro E, Canela R (2000) Insecticidal activity of maytenus species (Celastraceae) nortriterpene quinone methides against codling moth, Cydia pomonella (L.) (Lepidoptera: Tortricidae). J Agric Food Chem 48:88–92. https://doi.org/10.1021/jf990008w

Article  CAS  PubMed  Google Scholar 

Bai S, Gao W, Deng Q, Lin X, Zheng J, Chen Y, Tong L (2020) Pristimerin inhibits adjuvant arthritis fibroblast like synoviocytes cell proliferation through cell cycle arrest and induction of apoptosis. Indian J Pharm Sci 82:809–817

Article  CAS  Google Scholar 

Bi J, Areecheewakul S, Li Y, Yang S, Zhang Y, Ebeid K, Li L, Thiel KW, Zhang J, Dai D, Salem AK, Leslie KK, Meng X (2019) MTDH/AEG-1 downregulation using pristimerin-loaded nanoparticles inhibits Fanconi anemia proteins and increases sensitivity to platinum-based chemotherapy. Gynecol Oncol 155:349–358. https://doi.org/10.1016/j.ygyno.2019.08.014

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bicalho KU, Santoni MM, Arendt P, Zanelli CF, Furlan M, Goossens A, Pollier J (2019) CYP712K4 catalyzes the c-29 oxidation of friedelin in the Maytenus ilicifolia quinone methide triterpenoid biosynthesis pathway. Plant Cell Physiol 60:2510–2522. https://doi.org/10.1093/pcp/pcz144

Article  CAS  PubMed  Google Scholar 

Carvalho PRF, Silva DHS, Bolzani VS, Furlan M (2005) Antioxidant quinonemethide triterpenes from Salacia campestris. Chem Biodiver 2:367–372. https://doi.org/10.1002/cbdv.200590016

Article  CAS  Google Scholar 

Cevatemre B, Erkisa M, Aztopal N, Karakas D, Alper P, Tsimplouli C, Sereti E, Dimas K, Armutak EII, Gurevin EG, Uvez A, Mori M, Berardozzi S, Ingallina C, D’Acquarica I, Botta B, Ozpolat B, Ulukaya E (2018) A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer. Pharmacol Res 129:500–514. https://doi.org/10.1016/j.phrs.2017.11.027

Article  CAS  PubMed  Google Scholar 

Chang FR, Hayashi KI, Chen IH (2003) Antitumor agents. 228. Five new agarofurans, reissantins A-E, and cytotoxic principles from Reissantia buchananii. J Nat Prod 66:1416–1420. https://doi.org/10.1021/np030241

Article  CAS  PubMed  Google Scholar 

Chauhan K, Tripathi YC, Varshney VK (2023) Prinsepia utilis Royle: a review on its traditional uses, phytochemistry, and biological activities. Phytochem Lett 55:44–55. https://doi.org/10.1016/j.phytol.2023.03.009

Article  CAS  Google Scholar 

Cheng S, Zhang Z, Xing N, Xia Y, Pang B (2020) Pristimerin suppressed breast cancer progression via miR-542-5p/DUB3 axis. Oncotargets Ther 13:6651–6660. https://doi.org/10.2147/OTT.S257329

Article  CAS  Google Scholar 

Costa PMD, Ferreira PMP, Bolzani VDS (2008) Antiproliferative activity of pristimerin isolated from Maytenus ilicifolia (Celastraceae) in human HL-60 cells. Toxicol in Vitro 22:854–863. https://doi.org/10.1016/j.tiv.2008.01.003

Article  CAS  PubMed  Google Scholar 

Deeb D, Gao X, Liu YB, Pindolia K, Gautam SC (2014) Pristimerin, a quinonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt/NF-κB/mTOR signaling proteins and anti-apoptotic Bcl-2. Int J Oncol 44:1707–1715. https://doi.org/10.3892/ijo.2014.2325

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deng Q, Bai S, Gao W, Tong L (2015) Pristimerin inhibits angiogenesis in adjuvant-induced arthritic rats by suppressing VEGFR2 signaling pathways. Int Immunopharmacol 29:302–313. https://doi.org/10.1016/j.intimp.2015.11.001

Article  CAS  PubMed  Google Scholar 

Dong C, Xu C, Liu H, Xu S, Gao Y, Peng J (2015) Absorption and metabolism characterisitics of pristimerin as determined by a sensitive and reliable LC-MS/MS method. Fitoterpia 106:62–67. https://doi.org/10.1016/j.fitote.2015.08.006

Article  CAS  Google Scholar 

Edwards JM, Schwarting AE (1973) Isolation of pristimerin from Pachystima canbyi. Phytochemistry 12:945. https://doi.org/10.1016/0031-9422(73)80712-5

Article  CAS  Google Scholar 

El-Agamy DS, Shaaban MA, Almaramhy HH, Elkablawy S, Elkablawy MA (2018) Pristimerin as a novel hepatoprotective agent against experimental autoimmune hepatitis. Front Pharmacol 9:292. https://doi.org/10.3389/fphar.2018.00292

Article  CAS  PubMed  PubMed Central  Google Scholar 

El-Agamy DS, El-Harbi KM, Khoshhal S, Ahmed N, Elkablawy MA, Shaaban AA, Abo-Haded HM (2019) Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-κB signaling pathways. Cancer Manag Res 11:47–61. https://doi.org/10.2147/CMAR.S186696

Article  CAS  PubMed  Google Scholar 

Gamlath CB, Leslie Gunatilaka AA, Tezuka Y, Kikuchi T, Balasubramaniam S (1990) Quinone-methide, phenolic and related triterpenoids of plants of Celastraceae: further evidence for the structure of celastranhydride. Phytochemistry 29:3189–3192. https://doi.org/10.1016/0031-9422(90)80182-G

Article  CAS  Google Scholar 

Gao X, Liu Y, Deeb D, Arbab AS, Gautam SC (2014) Anticancer activity of pristimerin in ovarian carcinoma cells is mediated through the inhibition of prosurvival Akt/NF-κB/mTOR signaling. J Exp Ther Oncol 10:275–283

CAS  PubMed  PubMed Central  Google Scholar 

Gao X, Zhang Y, Wang Y, Zhang Y, Wang Y, Liu S, Gao X (2016) Influence of verapamil on pharmacokinetics of pristimerin in rats. Biomed Chromatograph 30:802–809. https://doi.org/10.1002/bmc.3611

Article  CAS  Google Scholar 

Gomes JPM, Cardoso CRP, Varanda EA, Molina JM, Fernandez MF, Olea N, Carlos IZ, Vilegas W (2011) Antitumoral, mutagenic and (anti)estrogenic activities of tingenone and pristimerin. Rev Bras Farmacogn 21:963–971. https://doi.org/10.1590/S0102-695X2011005000153

Article  CAS  Google Scholar 

Gonzalez AG, Alvarenga NL, Rodriguez F, Ravelo AG, Jimenez IA, Bazzochi IL, Gupta MP (1995) New phenolic and quinone-methide triterpenes from Maytenus species (Celastraceae). Nat Prod Lett 7:209–218. https://doi.org/10.1080/10575639508043213

Article  CAS  Google Scholar 

González-Félix MA, Mejía-Manzano LA, Barba-Dávila BA, Serna-Saldívar SO, González-Valdez J (2021) Optimized and scalable green extraction of pristimerin, an anticancerigen from Mortonia greggii, by ethanol-phosphate aqueous two-phase systems. Ind Eng Chem Res 60:5403–5410. https://doi.org/10.1021/acs.iecr.1c00473

Article  CAS  Google Scholar 

Gullo FP, Sardi JCO, Santos VAFFM, Leite FS, Pitangui NS, Rossi SA, Paula Silva ACA, Soares LA, Silva JF, Oliveira HC, Furlan M, Silva DHS, Bolzani VS, Mendes-Giannini MJS, Fusco-Almeida A (2012) Antifungal activity of maytenin and pristimerin. Evid-Based Compl Alt Med 2012:340787. https://doi.org/10.1155/2012/340787

Article  Google Scholar 

Gunatilaka AAL (1996) Triterpenoid quinonemethides and related compounds (celastroloids). Prog Chem Org Nat Prod vol 67. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9406-5_1

Hao X, Yuan J, Xu Y, Wang Z, Hou J, Hu T (2018) In vitro inhibitory effects of pristimerin on human liver cytochrome P450 enzymes. Xenobiotica 48:1185–1191. https://doi.org/10.1080/00498254.2017.1316886

Article  CAS  PubMed  Google Scholar 

Happi GM, Ntabo VK, Tcho AT, Wansi JD (2022) Naturally occurring dimeric triterpenoids: occurrence, chemistry and bioactivities. Phytochemistry 200:113242. https://doi.org/10.1016/j.phytochem.2022.113242

Article  CAS  PubMed  Google Scholar 

Harada R, Kakisawa H, Kobayashi S, Musya M, Nakanishi K, Takahashi Y (1962) Structure of pristimerin, a quinonoid triterpene. Tetrahedron Lett 14:603–607. https://doi.org/10.1016/S0040-4039(00)70915-4

Article  Google Scholar 

Hayashi D, Shirai T, Terauchi R, Tsuchida S, Mizoshiri N, Mori Y, Mazda O, Kubo T (2020) Pristimerin inhibits the proliferation of HT1080 fibrosarcoma cells by inducing apoptosis. Oncol Lett 19:2963–2970. https://doi.org/10.3892/ol.2020.11405

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hop NQ, Son NT (2022) Botanical description, traditional uses, phytochemistry, and pharmacology of the genus Artabotrys: a review. Chem Biodiver 19:e202200725. https://doi.org/10.1002/cbdv.202200725

Article  CAS  Google Scholar 

Huan DQ, Hop NQ, Son NT (2023) Oxymatrine: a current overview of its health benefits. Fitoterapia 168:105565. https://doi.org/10.1016/j.fitote.2023.105565

Article  CAS  PubMed  Google Scholar 

Huang S, He P, Peng X, Li J, Xu D, Tang Y (2015) Pristimerin inhibits prostate cancer bone metastasis by targeting PC-3 stem cell characteristics and VEGF-induced vasculogenesis of BM-EPCs. Cell Physiol Biochem 37:253–268. https://doi.org/10.1159/000430350

Article  CAS  PubMed  Google Scholar 

Huang D, Su L, He C, Chen L, Huang D, Peng J, Yang F, Cao Y, Luo X (2022) Pristimerin alleviates cigarette smoke-induced inflammation in chronic obstructive pulmonary disease via inhibiting NF-κB pathway. Biochem Cell Biol 100:223–235. https://doi.org/10.1139/bcb-2021-0251